Publications

J. Olver, G. O'Keefe, G. Jones, G. Burrows, H. Tochon-Danguy, U. Ackermann, A. Scott, T. Norman. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. Journal of Affective Disorders, Volume 114, Issue 1, Pages 321-326. PETNM-009-127

O’Keefe GJ, Saunder TH, Ng S, Ackermann U, Tochon-Danguy HJ, Chan G, Gong S, Pathmaraj K, Dyrks T, Lindemann S, Holl G, Villemagne V, Rowe CC. Radiation Dosimetry of the beta-amyloid Tracers 11C-PiB and 18F-BAY94-9172. J Nucl Med 49(S-1):283, 2008. PETNM-008-126

Lee ST, Ghanem M, Herbertson RA, Berlangieri SU, Byrne AJ, Tabone K, Mitchell P, Knight S, Feigen M, Scott AM. Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma. Mol Imag Biol (in press), 2008. PETNM-008-125

Scott AM, Gunawardana DH, Wong J, Kirkwood I, Hicks RJ, Ho Shon I, Ramshaw JE, Robins P. Positron Emission Tomography changes management, improves prognostic stratification and is superior to Gallium Scintigraphy in Patients with Low-Grade Lymphoma: Results of a Multi-Centre Prospective Study. E J Nucl Med Mol Imaging e-pub October, 2008. PETNM-008-124

Chaterton BE, Ho Shon I, Baldey A, Lenzo N, Patrikeos A, Kelly B, Wong D, Ramshaw JE, Scott AM. Positron Emission Tomography Changes Management and Improves Prognostic Stratification in Patients with Esophageal Cancer: Results of a Multi-Center Prospective Study. Eur J Nucl Med Mol Imag, e-pub October, 2008. PETNM-008-123

Scott AM, Gunawardana DH, Bartholomeusz D, Ramshaw JE, Lin P. Positron Emission Tomography changes management and improves prognostic stratification in patients with head and neck cancer: results of a multi-center prospective study. J Nucl Med J Nucl Med 49(9): 1593-1600, 2008. PETNM-008-122

Scott AM, Gunawardana DH, Stuckey JG, Byrne AJ, Ramshaw JE, Fulham MJ. Positron Emission Tomography changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multi-center prospective study. J Nucl Med 49(9): 1451-1457, 2008. PETNM-008-121

Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM. Established, emerging and future roles of PET/CT in the management of colorectal cancer: UK Perspective. Clinical Radiology (in press) October 2008. PETNM-008-120

He J, O’Keefe GJ, Gong SJ, Jones G, Saunder T, Scott AM, Geso, M. A novel method for respiratory motion gated with geometrical sensitivity of the scanner in PET. IEEE Transactions on Nuclear Science 55(5): (P-1) 2557-2565, 2008. PETNM-008-119

Pike KE., Rowe CC, Moss SA., Savage G. Memory profiling with paired associate learning in Alzheimer’s disease, mild cognitive impairment, and healthy aging. Neuropsychology 22(6):718-28,2008. PETNM-008-118

Ellis JR, Villemagne VL, Nathan PJ, Mulligan RS, Gong SJ, Chan JG, Sachinidis J, O’Keefe GJ, Pathmaraj K, Wesnes KA, Savage G, Rowe CC. Relationship between nicotinic receptors and cognitive function in early Alzheimer’s disease: A 2-[18F]Fluoro-A-85380 PET study. Neurobiology Learning Mem 90(2): 404-12,2008. PETNM-008-117

Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, and Rowe CC. The ART of Loss: A-b imaging in the evaluation of Alzheimer’s disease and other dementias. Molecular Neurobiology 38(1): 1-15,2008. PETNM-008-116

Gill S, Cosolo W, Herbertson RA, Berlangieri SU, Scott AM. Medullary Carcinoma of the Thyroid in a Patient with Colon Cancer and a rising CEA. Internal Medicine Journal (in press) 2008. PETNM-008-115

Lee ST, Tan T, Poon AMT, Toh HB, Gill S, Berlangieri SU, Kraft E, Byrne AJ, Pathmaraj K, O'Keefe GJ, Tebbutt N, Scott AM. Role of low dose, non-contrast CT from integrated PET/CT in evaluating incidental FDG-avid colon lesions. Molecular Imaging and Biology (in press) 2008. PETNM-008-114

Villemagne VL, KE Pike, D Darby, P Maruff, G Savage, S Ng, U Ackermann, TF Cowie, J Currie, SG Chan, G Jones, H Tochon-Danguy, G O’Keefe, CL Masters, and CC Rowe. A-b deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer’s disease. Neuropsychologia, 46:1688-1697, 2008. PETNM-008-112

Rimajova M, Lenzo NP, Wu JS, Bates KA, Campbell A, Dhaliwal SS, McCarthy M, Rodrigues M, paton A, Rowe C, Foster JK, Martins RN. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population. Journal of Alzheimers Disease, 13:137-46, 2008. PETNM-008-111

Rowe CC, Ackermann U, Browne W, Mulligan RS, Pike KE, O'Keefe G, Tochon-Danguy HJ, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe K, Kung HF, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL and Villemagne VL. Imaging of amyloid-b in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurology, 7: 129-135, 2008. PETNM-008-110

Raniga P, Bourgeat P, Villemagne V, O'Keefe G, Rowe CC and Ourselin S. Spline based inhomogeneity correction for 11C-PIB PET segmentation using expectation maximization. The Medical Image Computing and Computer-Assisted Intervention – International Conference, 10(Part 1): 228-235, 2007. PETNM-007-109

Bolton DM, Wong P, Lawrentschuk N. Renal cell carcinoma: imaging and therapy. Current Opinion in Urology 17(5): 337-40, 2007. PETNM-007-108

Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortés M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL. In vitro characterisation of Pittsburgh Compound-B (PIB) binding to Lewy Bodies. Journal of Neuroscience 27(39):10365–10371, 2007. PETNM-007-107

Lee, S.T. and Scott A.M.  Hypoxia Positron Emission Tomography Imaging With 18F-Fluoromisonidazole.  Seminars in Nuclear Medicine, 37(6), 451-461, 2007.  PETNM-007-106

Edison P., Rowe C.C., Rinne J.O., Ng S., Ahmed I., Kemppainen N., Villemagne V.L., O’Keefe G., Nagren K., Chaudhury K.R., Masters C.L., Brooks D.J.  Amyloid load in Parkinson’s disease: dementia and Lewy Body dementia measured with [C-11]PIB-PET.  J Neuro, Neurosurg, Psych, 2007. (In Press) PETNM-007-105

Pike K.E., Savage G., Villemagne V.L., Ng S., Moss S.A., Maruff P., Mathis C.A., Klunk W.E., Masters C.L., Rowe C.C.  β-amyloid imaging and memory in nondemented individuals: Evidence for preclinical Alzheimer’s disease.  Brain, 2007. (In Press)  PETNM-007-104

Ng S., Butzkueven H., Rowe C.C.  Prolonged interval between sentinel pseudotumoral demyelination and development of primary central nervous system lymphoma in a post-partum woman.  Journal of Clinical Neuroscience, 2007. (In Press)  PETNM-007-103

Villemagne V.L. and Rowe C.C.  The role of Ab imaging in the evaluation of early Alzheimer’s Disease.  Neuropsychologica, 2007. (In press)     PETNM-007-102

Lee S.T., Berlangieri S.U., Poon A.M.T., Mitchell P., Pathmaraj K., Tabone K., Byrne A.J., O'Keefe G.J., Knight S., Clarke P., Scott A.M.  Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.  Internal Medicine Journal, 2007 (Epub ahead of print) PMID: 17517082.  PETNM-007-101

Herbertson R.A., Lee S.T., Tebbutt N., Scott A.M.  The expanding role of PET technology in the management of patients with colorectal cancer.  Annals of Oncology, 2007. (Epub ahead of print) PMID: 17434894.  PETNM-007-100

Yücel M., Brewer W.J., Harrison B.J., Fornito A., O'Keefe G.J., Olver J., Scott A.M., Egan G.F., Velakoulis D., McGorry P.D., Pantelis C.  Anterior cingulate activation in antiphychotic-naïve first-episode schizophrenia.  Acta Psychiatrica et Neurologica Scandinavica, 115(2): 155-8, 2007.  PETNM-007-099

Ng S.Y., Villemagne V.L., Masters C.L., Rowe C.C.  Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B (11C-PIB PET).  Archives of Neurology, 64(8): 1140-1144, 2007.  PETNM-007-098

Rowe C.C., Ng S., Ackermann U., Gong S.J., Pike K., Savage G., Cowie T.F., Dickinson K.L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochon-Danguy H., O'Keefe G., Klunk W.E., Mathis C.A., Price J.C., Masters C.L., Villemagne V.L.  Imaging beta-amyloid burden in aging and dementia.  Neurology, 68(20): 1718-25, 2007.  PETNM-007-097

Ng S., Villemagne V.L., Berlangieri S.U., Lee S.T., Cherk M., Gong S.J., Ackermann U., Saunder T., Tochon-Danguy H., Jones G., Smith C., O’Keefe G., Masters C.L., Rowe C.C.  Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.  Journal of Nuclear Medicine, 48(4): 547-52, 2007.  PETNM-007-096

Lawrentschuk N., Bolton D.M., Davis I.D., Scott A.M.  Renal cell cancer and positron emission tomography – an evolving diagnostic and therapeutic relationship.  Current Medical Imaging Reviews, 3(1): 17-26, 2007.  PETNM-007-095

Lawrentschuk N., Davis I.D., Bolton D.M., Scott A.M.  Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.  International Journal of Urology, 14(2): 89-95, 2007.  PETNM-007-094

Merory J.R., Webster K.E., Wittwer J.E., Rowe C.C.  Quantitative gait analysis in patients with dementia with Lewy bodies and Alzheimer’s disease.  Gait and Posture, 26(3): 414-419, 2007.  PETNM-007-093

Scott A.M., Berlangieri S.U., MacFarlane, D.J.  Molecular Imaging. In: Clinical Nuclear Medicine.  G.J.R. Cook, M.N. Maisey, K.E. Britton and V. Chengazi (Eds.), Hodder Arnold, London, 4th Edition, Chapter 1, 5-27, 2006.  PETNM-B06-010

Villemagne V.L., Ng S., Cappai R., Barnham K.J., Fodero-Tavoletti M.T., Rowe C.C., Masters C.L.  La Lunga Attesa: Towards a molecular approach to neuroimaging and therapeutics in Alzheimer’s disease.  The Neuroradiology Journal, 19(4): 51-75, 2006.  PETNM-006-092

Masters C.L., Cappai R., Barnham K.J., Villemagne V.L.  Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.  Journal of Neurochemistry, 97(6): 1700-25, 2006.  PETNM-006-091

Horti A.G., Villemagne V.L.  The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.  Current Pharmaceutical Design, 12(30): 3877-900, 2006.  PETNM-006-090

Cherk M.H., Foo S., Poon A.M.T., Knight S., Murone C, Papenfus AT, Sachinidis J., Saunder T., O'Keefe G.J., Scott A.M.  Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by F-Fluoromisonidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography.  Journal of Nuclear Medicine, 47(12): 1921-1926, 2006.  PETNM-006-089

Lawrentschuk N., Poon A.M.T., Scott A.M.  Fluorine-18 fluorothymidine: a new positron emission radioisotope for renal tumours.  Clinical Nuclear Medicine, 31(12): 788-789, 2006.  PETNM-006-088

Carey L.M., Abbott D.F., Egan G.F., O'Keefe G.J., Jackson G.D., Bernhardt J., Donnan G.A.  Evolution of brain activation with good and poor motor recovery after stroke.  Neurorehabilitation and Neural Repair, 20(1): 24-41, 2006.  PETNM-006-087

Falzon C.L., Ackermann U., Spratt N., Tochon-Danguy H.J., White J., Howells D., Scott A.M.  F-18 labelled N,N-Bis-haloethylamino-phenylsulfoxides - A new class of compounds for the imaging of hypoxic tissue.  Journal of Labelled Compounds and Radiopharmaceuticals, 49(12): 1089-1103, 2006.  PETNM-006-086

Perera M.N., Ma H.K., Arakawa S., Howells D.W., Markus R., Rowe C.C., Donnan G.A.  Inflammation following stroke. Journal of Clinical Neuroscience, 13(1): 1-8, 2006.  PETNM-006-085

Belhocine T, Scott A.M., Even-Sapir E., Essner R.  The Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma.  Journal of Nuclear Medicine, 47(6): 957-967, 2006.  PETNM-006-084

Lawrentschuk N., Rigopoulos A., Lee F.T., Davis I.D., Scott A.M., Bolton D.M.  Xenografting tumour beneath the renal capsule using modern surgical equipment.  European Surgical Research, 38(3): 340-346, 2006.  PETNM-006-083

Essner R., Belhocine T., Scott A.M., Even-Sapir E.  Novel Imaging Techniques in Melanoma.  Surgical Oncology Clinics of North America, 15(2): 253-83, 2006.  PETNM-006-082

Harrison B.J., Yücel M., Shaw M., Kyrios M., Maruff P., Brewer W.J., Purcell R., Velakoulis D., Strother S.C., Scott A.M., Nathan P.J., Pantelis C.  Evaluating brain activity in obsessive-compulsive disorder: Preliminary insights from a multivariate analysis.  Psychiatry Research, 147(2-3): 227-231, 2006.  PETNM-006-081

Fedi M., Berkovic S., Marini C., Mulligan R., Tochon-Danguy H.J., Reutens D.  A GABAA Receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage, 32(3): 995-1000, 2006.  PETNM-006-080

Spratt N.J., Ackermann U., Tochon-Danguy H.J., Donnan G.A., Howells D.W. Characterization of Fluoromisonidazole Binding in Stroke. Stroke, 37(7): 1862-67, 2006.  PETNM-006-079

Ackermann U., Blanc P., Falzon C., Issa W., White J., Tochon-Danguy H.J., Sachinidis J.I., Scott A.M.  Synthesis of 11C labelled methyl esters: Transesterification of enol esters versus BF3 catalysed esterification – a comparative study. Radiation Physics and Chemistry, 75(1): 48-52, 2006.  PETNM-006-078

Lawrentschuk N., Davis I.D., Bolton D.M., Scott A.M. Positron Emission Tomography (PET), Immuno-PET and Radioimmunotherapy in Renal Cell Cancer: a Developing Diagnostic and Therapeutic Relationship. British Journal of Urology International, 97(5): 916-22, 2006.  PETNM-006-077

Cher L.M., Murone C., Lawrentschuk N., Ramdave S., Papenfuss A., Hannah A., O'Keefe G.J., Sachinidis J.I., Berlangieri S.U., Fabinyi G., Scott A.M.  Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Gliomas using 18F-Fluoromisonidazole (FMISO) & 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Immunohistochemical Studies. Journal of Nuclear Medicine, 47(3): 410-18, 2006.  PETNM-006-076

Lawrentschuk N., Davis I.D., Bolton D.M., Scott A.M. Positron Emission Tomography and Molecular Imaging of the Prostate: an Update. British Journal of Urology International, 97(5): 923-31, 2006.  PETNM-006-075

Opazo C., Luza S., Villemagne V.L., Volitakis I., Rowe C.C., Barnham K.J., Strozyk D., Masters C.L., Cherny R.A., Bush A.L.  Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease. Aging Cell, 5(1): 69-79, 2006.  PETNM-006-074

Derry C., Benjamin C., Bladin P., le Bars D., Tochon-Danguy H.J., Berkovic S.F., Zimmer L., Costes N., Mulligan R., Reutens D.  Increased serotonin receptor availability in human sleep: Evidence from an [(18)F]MPPF PET study in narcolepsy. Neuroimage, 30(2): 341-8, 2006.  PETNM-006-073

Scott A.M. PET Imaging in Oncology. In: Positron Emission Tomography. Basic Sciences. D.L. Bailey, D.W. Townsend, P.E. Valk, M.N. Maisey (Eds.), Springer-Verlag, London, UK, 2005. PETNM-B05-005

Rowe CC. Single-photon-emission computed tomography in epilepsy. In: Magnetic Resonance in Epilepsy. Neuroimaging techniques. R. Kuzniecky, G. Jackson (Eds). Elsevier Academic Press, UK. 2nd Edition, Chapter 14, 385-394, 2005. PETNM-B05-004

Rowe CC. Single Photon Emission Computed Tomography in Epilepsy. In: Epilepsy Surgery: Principles and Controversies. J.W. Miller and D.L. Silbergeld (Eds). Taylor and Francis Publishing Group, Oxford, UK. Chapter 20, 2005;383-395. PETNM-B05-003

Yap K.K., Saunder T.H., Poon A. Increased F-18 FDG skeletal muscle uptake secondary to altered weight bearing and the use of crutches. Clinical Nuclear Medicine, 30(12): 806-7, 2005.  PETNM-005-072

Hicks R.J., Rischin D., Fisher R., Binns D., Scott A.M., Peters L.J.  Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.  European Journal of Nuclear Medicine And Molecular Imaging, 32(12): 1384-1391, 2005.  PETNM-005-071

Novakovic K.E., Villemagne V.L., Rowe C.C., Masters C.L. Rare genetically defined causes of dementia.  International Psychogeriatrics, 17(S1): S149-194, 2005.  PETNM-005-070

Mitkovski S., Villemagne V.L., Novakovic K.E., O’Keefe G, Tochon-Danguy H., Mulligan R.S., Dickinson K.L., Saunder T., Gregoire M.C., Bottlaender M., Dolle F., Rowe C.C.  Simplified quantitation of nicotinic receptors with 2[18F]F-A-85380 PET.  Nuclear Medicine & Biology, 32(6): 585-591, 2005.  PETNM-005-069

Ollenberger G.P., Byrne A.J., Berlangieri S.U., Rowe C.C., Pathmaraj K., Reutens D.C., Berkovic S.F., Scheffer I.E., Scott A.M.  Assessment of the role of FDG-PET in the Diagnosis and Management of Children with Refractory Epilepsy.  European Journal of Nuclear Medicine & Molecular Imaging, 32(11): 1311-6, 2005.  PETNM-005-068

Harris M.T., Berlangieri S.U., Cebon J.S., Davis I.D., Scott A.M.  Impact of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with advanced melanoma.  Molecular Imaging & Biology, 23(1): 1-5, 2005.  PETNM-005-067

Villemagne V.L., Rowe C.C., Macfarlane S., Novakovic K.E., Masters C.L. Imaginem Oblivionis. The prospects of neuroimaging for early detection in Alzheimer’s disease. Journal of Clinical Neuroscience, 12(3): 221-30, 2005.  PETNM-005-066

Roberts F.O., Gunawardana D.H., Pathmaraj K., Cuneen M., Wallace A., U P., Mi T.,  Berlangieri S.U., O'Keefe G.J., Rowe C.C., Scott A.M.  Radiation Dose to PET Technologists and Strategies to Lower Occupational Exposure. Journal of Nuclear Medicine Technology, 33(1): 44-47, 2005.  PETNM-005-065

Ackermann U., Tochon-Danguy H.J., Nerrie M., Nice E.C., Sachinidis J.I., Scott A.M. Synthesis, 11C labeling and biological properties of derivatives of the tyrphostin AG957. Nuclear Medicine & Biology, 32(4): 323-8, 2005.  PETNM-005-064

Lawrentschuk N., Poon A.M., Foo S.S., Johns Putra L.G., Murone C., Davis I.D., Bolton D.M., Scott A.M. Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography. British Journal of Urology International, 96(4): 540-6, 2005.  PETNM-005-063

Yap K.K., Yap K.S., Byrne A.J., Berlangieri S.U., Poon A., Mitchell P., Knight S.R., Clarke P.C., Harris A., Tauro A., Rowe C.C., Scott A.M. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.  European Journal of Nuclear Medicine & Molecular Imaging, 32(9): 1033-40, 2005.  PETNM-005-062

Ackermann U., Tochon-Danguy H.J., Scott A.M. BF3 Etherate Catalysed Formation of [11C]-methyl esters: A novel radiolabelling technique.  Journal of Labelled Compounds and Radiopharmaceuticals, 47(8): 523-30, 2004.  PETNM-004-061

Ollenberger G.P. and Berlangieri S.U.  Splenic infarction mimicking gastric remnant on PET imaging.  Clinical Nuclear Medicine, 29(1): 37-8, 2004.  PETNM-004-060

Johns Putra L., Lawrentschuk N., Ballok Z., Hannah A., Poon A., Tauro A., Davis I.D., Hicks R.J., Bolton D.M., Scott A.M. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.  Urology, 64(6): 1202-7, 2004.  PETNM-004-059

Foo S.S., Ramdave S., Berlangieri S.U., Scott A.M. Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.  Australasian Radiology, 48(2): 214-6, 2004.  PETNM-004-058

Foo S.S., Mitchell P.L., Berlangieri S.U., Smith C.L., Scott A.M. Positron emission tomography scanning in the assessment of patients with lymphoma.  Internal Medicine Journal, 34(7): 388-97, 2004.  PETNM-004-057

Foo S.S., Abbott D.F., Lawrentschuk N., Scott A.M. Functional imaging of intratumoral hypoxia.  Molecular Imaging & Biology, 6(5): 291-305, 2004.  PETNM-004-056

Issa W., Tochon-Danguy H.J., Lambert J., Sachinidis J.I., Ackermann U., Liu Z., Scott A.M. Synthesis and evaluation of a thymidine analog for positron emission tomography study of tumor DNA proliferation in vivo.  Nuclear Medicine & Biology, 31(7): 839-49, 2004.  PETNM-004-055

Markus R., Reutens D.C., Kazui S., Read S., Wright P., Pearce, D.C., Tochon-Danguy H.J., Sachinidis J.I., Donnan G.A.  Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain, 127(6): 1427-1436, 2004.  PETNM-004-054

Clark C.R., McFarlane A.C., Morris P., Weber D.L., Sonkkilla C., Shaw M., Marcina J., Tochon-Danguy H.J., and Egan G. F. Cerebral function in posttraumatic stress disorder during verbal working memory updating: a positron emission tomography study.  Biological Psychiatry, 53(6): 474-81, 2003.  PETNM-003-053

Copolov D.L., Seal M.L., Maruff P., Ulusoy R., Wong M.T., Tochon-Danguy H.J., and Egan G.F.  Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study.  Psychiatry Research, 122(3): 139-52, 2003.  PETNM-003-052

Froomes P.R., Sachinidis J., Ghabrial H., Tochon-Danguy H., Scott A.M., Ching M. S., Morgan D.J., Angus P.W.  A novel method for determining hepatic sinusoidal oxygen permeability in the isolated perfused rat liver using [15O]O2.  Nuclear Medicine & Biology, 30(2): 93-100, 2003.  PETNM-003-051

Markus R., Reutens D.C., Kazui S., Read S., Wright P., Chambers B.R., Sachinidis J.I., Tochon-Danguy H.J., Donnan G.A. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke.  Stroke, 34(11): 2646-52, 2003.  PETNM-003-050

Lee F.T. and Scott A.M.  Immuno-PET for tumor targeting.  Journal of Nuclear Medicine, 44(8): 1282-3, 2003.  PETNM-003-049

Mitchell P., Lee F.T., Hall C., Rigopoulos A., Smyth F.E., Hekman A.M., van Schijndel G.M., Powles R., Brechbiel M.W., Scott A.M.  Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.  Journal of Nuclear Medicine, 44(7): 1105-12, 2003.  PETNM-003-048

Weintrob D.L., Saling M.M., Berkovic S.F., Berlangieri, S.U., Reutens D.C.  Verbal memory in left temporal lobe epilepsy: evidence for task-related localization.  Annals of Neurology, 51(4): 442-7, 2002.  PETNM-002-047

Tochon-Danguy H.J., Sachinidis J.I., Chan F., Chan J.G., Hall C., Cher L., Stylli S., Hill J., Kaye A., Scott A.M.  Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).  Nuclear Medicine & Biology, 29(2): 191-7, 2002.  PETNM-002-046

Markus R., Donnan G.A., Kazui S., Read S., Hirano T., Scott A.M., O’Keefe G.J., Tochon-Danguy H.J., Sachinidis J.I., Reutens D.C.  Statistical parametric mapping of hypoxic tissue identified by [(18)F]fluoromisonidazole and positron emission tomography following acute ischemic stroke.  Neuroimage, 16(2): 425-33, 2002.  PETNM-002-045

Scott A.M.  Current status of positron emission tomography in oncology.  Australasian Radiology, 46(2): 154-62, 2002.  PETNM-002-044

Hannah A., Scott A.M., Tochon-Danguy H., Chan J.G., Akhurst T., Berlangieri S., Price D., Smith G.J., Schelleman T., McKay W.J., Sizeland A.  Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.  Annals of Surgery, 236(2): 208-17, 2002.  PETNM-002-043

Liu Z., Lee F.T., Hanai N., Smyth F.E., Burgess A.W., Old L.J., Scott A.M.  Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.  Cancer Immunity, 2(13): 7, 2002.  PETNM-002-042

Liu Z., Smyth F.E., Renner C., Lee F.T., Oosterwijk E., Scott A.M.  Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. .  Cancer Immunology, Immunotherapy, 51(3): 171-7, 2002.  PETNM-002-041

Cunnington R., Egan G.F., O'Sullivan J.D., Hughes A.J., Bradshaw J.L., Colebatch J.G.  Motor imagery in Parkinson's disease: a PET study.  Movement Disorders, 16(5): 849-57, 2001.  PETNM-001-040

Fedi M., Reutens D., Okazawa H., Andermann F., Boling W., Dubeau F., White C., Nakai A., Gross D.W., Andermann E., Diksic M.   Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin.  Neurology, 57(9): 1629-36, 2001.  PETNM-001-039

Fedi M., Reutens D., Dubeau F., Andermann E., D'Agostino D., Andermann F.  Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy.  Archives of Neurology, 58(5): 781-6, 2001.  PETNM-001-038

Lee F.T., Rigopoulos A., Hall C., Clarke K., Cody S.H., Smyth F.E., Liu Z., Brechbiel M.W., Hanai N., Nice E.C., Catimel B., Burgess A.W., Welt S., Ritter G., Old L.J., Scott A.M.  Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.  Cancer Research, 61(11): 4474-82, 2001.  PETNM-001-037

Lee F.T., Hall C., Rigopoulos A., Zweit J., Pathmaraj K., O'Keefe G.J., Smyth F.E., Welt S., Old L.J., Scott A.M.   Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.  Journal of Nuclear Medicine, 42(5): 764-9, 2001.  PETNM-001-036

Power B.E., Caine J.M., Burns J.E., Shapira D.R., Hattarki M.K., Tahtis K., Lee F.T., Smyth F.E., Scott A.M., Kortt A.A., Hudson P.J.  Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector.  Cancer Immunology, Immunotherapy, 50(5): 241-50, 2001.  PETNM-001-035

Ramdave S., Thomas G.W., Berlangieri S.U., Bolton D.M., Davis I., Danguy H.T., Macgregor D., Scott A.M.  Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.  Journal of Urology, 166(3): 825-30, 2001.  PETNM-001-034

Renner C., Stehle I., Lee F.T., Hall C., Catimel B., Nice E.C., Mountain A., Rigopoulos A., Brechbiel M.W., Pfreundschuh M., Scott A.M.  Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system.  Cancer Immunology, Immunotherapy, 50(2):102-8, 2001.  PETNM-001-033

Rowe C.C., Allman K.   Cost-effectiveness and accuracy of exercise stress echocardiography in the non-invasive diagnosis of coronary heart disease.  Internal Medicine Journal, 31(6): 375-7, 2001.  PETNM-001-032

Scott A.M., Lee F.T., Hopkins W., Cebon J.S., Wheatley J.M., Liu Z., Smyth F.E., Murone C., Sturrock S., MacGregor D., Hanai N., Inoue K., Yamasaki M., Brechbiel M.W., Davis I.D., Murphy R., Hannah A., Lim-Joon M., Chan T., Chong G., Ritter G., Hoffman E.W., Burgess A.W., Old L J.  Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.  Journal of Clinical Oncology, 19(19): 3976-87, 2001.  PETNM-001-031

Scott A.M.  Current status of positron emission tomography in oncology.  Internal Medicine Journal, 31(1): 27-36, 2001.  PETNM-001-030

Tahtis K., Lee F.T., Smyth F.E., Power B.E., Renner C., Brechbiel M.W., Old L.J., Hudson P.J., Scott A.M.  Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. Clinical Cancer Research, 7(4): 1061-72, 2001.  PETNM-001-029

Clark C.R., Egan G.F., McFarlane A.C., Morris P., Weber D., Sonkkilla C., Marcina J., and Tochon-Danguy H.J.  Updating working memory for words: a PET activation study.  Human Brain Mapping, 9(1): 42-54, 2000.  PETNM-000-028

Read S.J., Hirano T., Abbott D.F., Markus R., Sachinidis J.L., Tochon-Danguy H.J., Chan G.J., Egan G.F., Scott A.M., Bladin C.F., McKay W.J., Donnan G.A.  The fate of the penumbra and its relationship to clinical outcome after ischaemic stroke studied with 18F-Fluoromisonidazole PET.  Annals of Neurology, 48(2): 228-35, 2000.  PETNM-000-027

Carey L.M., Abbott D.F., Egan G.F., Tochon-Danguy H.J., Donnan G.A.  The functional neuroanatomy and long-term reproducibility of brain activation associated with a simple finger tapping task in older healthy volunteers: a serial PET study.  Neuroimage, 11(2): 124-44, 2000.  PETNM-000-026

Castiello U., Bennett K.M., Egan G.F., Tochon-Danguy H.J., Kritikos A., Dunai J. Human inferior parietal cortex ‘programs’ the action class of grasping: A positron emission tomography study.  Journal of Cognitive Systems Research, 1(2): 89-79, 2000.  PETNM-000-025

Cowell S., Code C., Egan G.F., Harasty J., Watson J.D.  The functional neuroanatomy of simple calculation and number repetition: A parametric PET activation study.  Neuroimage, 12(5): 565-73, 2000.  PETNM-000-024

Harris I.M., Egan G.F., Sonkilla C., Tochon-Danguy H., Paxinos G., Watson J.D. Selective right parietal lobe activation during mental rotation: a parametric PET study. Brain, 123(1): 65-73, 2000.  PETNM-000-023

Hirano T., Read S.J., Abbott D.F., Sachinidis J.L., Tochon-Danguy H.J., Egan G.F., Bladin C.F., Scott A.M., Donnan G.A.  No Evidence of Hypoxic Tissue Surrounding an Intracerebral Haemorrhage using PET and 18F-Fluoromisonidazole.  Neurology, 53(9): 2179-82, 1999.  PETNM-099-022

Code C., Cowell S.F., Egan G.F., Watson J.D., Harasty J.  Mental calculation and number word repetition: A PET study.  Brain and Language, 68: 490-492, 1999.  PETNM-099-021

Tochon-Danguy H.J., Sachinidis J.I., Egan G.F., Chan J.G., Berlangieri S.U., McKay W.J., Scott A.M.  Positron Emission Tomography: Radioisotope and Radiopharmaceutical Production.  Australasian Physical & Engineering Sciences in Medicine, 22(4): 136-44, 1999.  PETNM-099-020

Reutens D.C., Bittar R.G., Tochon-Danguy H.J., Scott A.M.  Clinical applications of [15O] H20 PET activation studies.  Clinical Positron Imaging, 2(3): 145-152, 1999.  PETNM-099-019

Pointon O., Scott A.M., Berlangieri S., McKay W.J., Goldstein D.  F-18 fluorodeoxyglucose PET and Ga-67 citrate scintigraphy in a case of AIDS lymphoma and pericarditis.  Clinical Nuclear Medicine, 24(10): 817-8, 1999.  PETNM-099-018

Berlangieri S.U., Scott A.M., Knight S.R., Fitt G.J., Hennessy O.F., Tochon-Danguy H.J., Clarke C.P., McKay W.J.  F-18 Fluorodoexyglucose Positron Emission Tomography in the Non-Invasive Staging of Non-Small Cell Lung Carcinoma.  European Journal of Cardio Thoracic Surgery, 16(1): S25-S30, 1999.  PETNM-099-017

Wenderoth P., Watson J.D., Egan G.F., Tochon-Danguy H.J., O'Keefe G.J.  Second order components of moving plaids activate extrastriate cortex: a positron emission tomography study.  Neuroimage 9(2):227-234, 1999.  PETNM-099-016

Kiffer J., Berlangieri S.U., Scott A.M., Quong G., Feigen M., Clarke C.P., Knight S.R., Daniel F.R.  The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging (FDG-PET) to radiotherapy planning in lung cancer.  Lung Cancer, 19(3): 167-77, 1998.  PETNM-098-015

Thomas D.M., Mitchell P.L., Berlangieri S.U., Tochon-Danguy H., Knight S., Clarke C.P., Scott A.M.  Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small cell lung cancer.  Medical Journal of Australia, 169(4): 227, 1998.  PETNM-098-014

Read S.J., Hirano T., Abbott D.F., Sachinidis J.I., Tochon-Danguy H.J., Chan J.G., Egan G.F., Scott A.M., Bladin C.F., McKay W.J., Donnan G.A.  Identifying hypoxic tissue after ischemic stroke using PET and 18F-Fluoromisonidazole.  Neurology 51(6): 1617-21, 1998.  PETNM-098-013

Kalff V., Every B.V., Barton H.J., Bergin P.J., Esmore D.S., Berlangieri S.U., Kelly M.J.  The limited role of myocardial fluorine-18 fluorodeoxyglucose imaging in candidates for cardiac transplantation: a planar imaging study.  European Journal of Nuclear Medicine & Molecular Imaging, 25(3): 253-8, 1998.  PETNM-098-012

Patterson H., Clarke G.H., Guy R., McKay W.J.  Head movement in normal subjects during simulated brain imaging.  Journal of Nuclear Medicine Technology, 26(4): 257-61, 1998.  PETNM-098-011

Barnes D., Egan G., O'Keefe G., Abbott D.  Characterization of dynamic 3-D PET imaging for functional brain mapping.  IEEE Transactions on Medical Imaging, 16(3): 261-9, 1997.  PETNM-097-010

O'Brien T.J., Newton M.R., Cook M.J., Berlangieri S.U., Kilpatrick C., Morris K., Berkovic S.F.  Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy.  Epilepsia, 38(1): 74-80, 1997.  PETNM-097-009

Chan R.K., Lee K.J., Calafiore P., Berlangieri S.U., McKay W.J., Tonkin A.M. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. Journal of the American College of Cardiology, 27(7): 1601-7, 1996.  PETNM-095-008

Hannah A., Scott A.M., Akhurst T, Berlangieri S.U., Bishop J, McKay JW. Abnormal colonic accumulation of fluorine F18-FDG in pseudomembranous colitis.  Journal of Nuclear Medicine, 37(10): 1683-5, 1996.  PETNM-095-007

Chan R.K., Lee K.J., Berlangieri S.U., Tonkin AM. Assessment of idiopathic dilated cardiomyopathy using positron emission tomography (PET).  Australian and New Zealand Journal of Medicine, 25(3): 245-7, 1995.  PETNM-095-006

Tochon-Danguy H.J., Clark J.C., Janus A., Sachinidis J.I.  Technical Performance and Operating Procedure of a Bedside [15O] Water Infuser.  Journal of Labelled Compounds and Radiopharmaceuticals, 37: 662-6, 1995.  PETNM-095-005

Scott A.M., Berlangieri S.U.  Positron Emission Tomography in Colorectal Carcinoma.  Diagnostic Oncology, 4(2-3): 123-9, 1995.  PETNM-095-004

Kalff V., Berlangieri S.U., Van Every B., Rowe J.L., Lambrecht R.M., Tochon-Danguy H.J., Egan G.F., McKay W.J., Kelly M.J.  Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?  European Journal of Nuclear Medicine & Molecular Imaging, 22(7): 625-63, 1995.  PETNM-095-003

Ho SS, Berkovic S.F., Berlangieri S.U., Newton M.R., Egan G.F., Tochon-Danguy H.J., McKay W.J. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy.  Annals of Neurology, 37(6): 738-745, 1995.  PETNM-095-002

Egan G.F., Liu Z.Q.  Computers and networks in medical and healthcare systems. Computers in Biology and Medicine, 25(3): 355-365, 1995.  PETNM-095-001